Position in BBNX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$25,072,000
+$2,912,590 QoQ
Shares Held
1,600,000
-27.7% QoQ
Ownership
3.56%
of shares outstanding
% of Portfolio
0.59%
of 13F equity value
Holder Rank
#8
of 133 holders
Holding Since
Jun 2025
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BBNX Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026Vestal Point Capital, LP holds $480,553,000 across 7 Medical Devices names. BBNX ranks #6 (5.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABT |
Abbott Laboratories
|
1,400,000 | $127,036,000 | |
| 2 | ZBH |
Zimmer Biomet Holdings, Inc.
|
1,400,000 | $120,526,000 | |
| 3 | PODD |
Insulet Corp
|
670,000 | $102,007,500 | |
| 4 | GMED |
Globus Medical Inc
|
850,000 | $67,158,500 | |
| 5 | GEHC |
GE HealthCare Technologies Inc.
|
450,000 | $28,804,500 | |
| 6 | BBNX |
Beta Bionics, Inc.
This page
|
1,600,000 | $25,072,000 | |
| 7 | AVR |
Anteris Technologies Global Corp.
|
1,010,000 | $9,948,500 |
All Filings in BBNX
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $25,072,000 | 1,600,000 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $22,159,410 | 2,211,518 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $18,282,000 | 600,000 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $11,922,000 | 600,000 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $8,008,000 | 550,000 | Shares | Sole | 2025-08-14 | |
| No filing history on record for this holder in this stock. | ||||||